HAEMATOPOIETIC STEM CELL MOBILISATION

HAEMATOPOIETIC STEM CELL MOBILISATION was reported 64 times

HAEMATOPOIETIC STEM CELL MOBILISATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 17 0.0016
1 Hematopoietic Stem Cell Mobilizer [EPC] 2 0.0013
2 CD38-directed Cytolytic Antibody [EPC] 5 0.0009
3 Topoisomerase Inhibitor [EPC] 31 0.0004
4 Lipid-based Polyene Antifungal [EPC] 4 0.0003
5 Alkylating Drug [EPC] 40 0.0002
6 Penem Antibacterial [EPC] 4 0.0001
7 Leukocyte Growth Factor [EPC] 15 0.0001
8 Programmed Death Receptor-1 Blocking Antibody [EPC] 10 0.0001
9 Polyene Antifungal [EPC] 4 0.0001
10 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
11 Phosphodiesterase 5 Inhibitor [EPC] 11 0.0001
12 Platinum-based Drug [EPC] 20 0.0001
13 CD20-directed Cytolytic Antibody [EPC] 23 0.0001
14 Nucleoside Metabolic Inhibitor [EPC] 19 0.0001
15 Provitamin D2 Compound [EPC] 2 0.0001
16 BCL-2 Inhibitor [EPC] 4 0.0001
17 Proteasome Inhibitor [EPC] 7 0.0001
18 Corticosteroid [EPC] 40 0.0000
19 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
20 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
22 Prostacycline Vasodilator [EPC] 2 0.0000
23 Azole Antifungal [EPC] 2 0.0000
24 Kinase Inhibitor [EPC] 6 0.0000
25 Endothelin Receptor Antagonist [EPC] 2 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 13 0.0000
27 Thalidomide Analog [EPC] 4 0.0000
28 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
29 Aldosterone Antagonist [EPC] 1 0.0000
30 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 Osmotic Laxative [EPC] 1 0.0000
33 Insulin Analog [EPC] 1 0.0000
34 Loop Diuretic [EPC] 1 0.0000
35 Benzodiazepine [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000